Drugs Archives - Page 47 of 66

Podcast: KHN’s ‘What The Health?’ Falling Premiums And Rising Political Tensions

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the Trump administration’s announcement that average premium prices are falling on the Obamacare marketplaces, the effort by Senate Democrats to reverse rules on short-term health insurance and the focus on protections for people with preexisting conditions in the run-up to midterm elections.

Oct. 11, 2018

No More Secrets: Congress Bans Pharmacist ‘Gag Orders’ On Drug Prices

Congress approved two bills last month that prohibit provisions keeping pharmacists from telling patients when they can save money by paying the cash price instead of the price negotiated by their insurance plan.

By Susan Jaffe

Oct. 10, 2018

Black Market For Suboxone Gives Some A Glimpse Of Recovery

Addiction experts argue that buprenorphine, which drug users buy on the street, actually saves lives because it is used in place of more dangerous substances, like heroin and fentanyl.

By Jake Harper, Side Effects Public Media

Oct. 9, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Oct. 5, 2018

In The Battle To Control Drug Costs, Old Patent Laws Get New Life

Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.

By Shefali Luthra

Oct. 5, 2018

Congress Targets Misuse Of Hospice Drugs

In the bipartisan opioid bill headed to the president’s desk, hospice workers would be allowed to destroy patients’ unneeded opioids, reducing the risk that families misuse them.

By Melissa Bailey

Oct. 4, 2018

Podcast: KHN’s ‘What The Health?’ Some Things Old, Some Things New

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner discuss final action on bills in Congress to address the opioid epidemic and fund federal health agencies. They also look at new efforts by the Food and Drug Administration to crack down on teen nicotine use.

Oct. 4, 2018

VA Adding Opioid Antidote To Defibrillator Cabinets For Quicker Overdose Response

A project that started in a Boston Veterans Affairs facility will soon go nationwide. It puts naloxone, also known as Narcan, into emergency supplies cabinets throughout the VA system.

By Martha Bebinger, WBUR

Oct. 3, 2018

Drugmakers Play The Patent Game To Lock In Prices, Block Competitors

Pharmaceutical companies like Purdue Pharma, maker of OxyContin, often win patents for incremental changes with debatable value. Now there’s a twist involving an opioid treatment.

By Sarah Jane Tribble

Oct. 2, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Sept. 28, 2018

Podcast: KHN’s ‘What The Health?’ (Almost) Live from Austin!

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Ollstein of Politico talk about how health issues will play in midterm elections, the Trump administration’s move that could penalize legal immigrants who use government aid programs, and other topics. Due to technical difficulties, the original discussion taped Sept. 27 at the 2018 Texas Tribune Festival could not be broadcast, so the panelists reconvened from Austin and Washington on Sept. 28.

Sept. 28, 2018

Buried In Congress’ Opioid Bill Is Protection For Personal Drug Imports

The protection is a win for people who get their needed, legitimate drugs from overseas.

By Michael McAuliff

Sept. 27, 2018

Letters To The Editor

Readers And Tweeters Slice And Dice Precision Medicine, Step Therapy

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

Sept. 26, 2018

Workers Overdose On The Job, And Employers Struggle To Respond

Despite the growing epidemic of Americans misusing opioids and overdosing on the job, many employers turn a blind eye to addiction within their workforce — ill-equipped or unwilling to confront an issue they are at a loss to handle.

By Jenny Gold

Sept. 25, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Sept. 21, 2018

As States Try To Rein In Drug Spending, Feds Slap Down One Bold Medicaid Move

Medicaid drug spending doubled in five years in Massachusetts. The state wanted to exclude expensive drugs that weren't proven to work better than existing alternatives from its Medicaid plan, but the federal government blocked the effort.

By Martha Bebinger, WBUR

Sept. 21, 2018

New Medicare Advantage Tool To Lower Drug Prices Puts Crimp In Patients’ Choices

Federal officials are allowing the private insurance plans to use “step therapy” for drugs administered by doctors. In step therapy, patients must first use cheaper drugs to see if they work before receiving more expensive options.

By Susan Jaffe

Sept. 17, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Sept. 14, 2018

Insurer To Purdue Pharma: We Won’t Pay For OxyContin Anymore

Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.

By Blake Farmer, Nashville Public Radio

Sept. 13, 2018

Unwitting Patients, Copycat Comments Play Hidden Role In Federal Rule-Making

As HHS decided to cut $1.6 billion in drug payments to hospitals, it weighed thousands of comments generated by a pharmaceutical-funded advocacy group.

By Sarah Jane Tribble

Sept. 11, 2018

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs